Shaping a future free from Alzheimer's disease
Researchers in Madison are partnering with a Milwaukee-based Latino community center to create a new, culturally competent, elective course for medical students at the University of Wisconsin School of Medicine and Public Health as an elective.
Nathaniel Chin, MD, medical director of the WRAP study, appeared on numerous Wisconsin news outlets to discuss the recent Food and Drug Administration (FDA) approval of a blood test for Alzheimer’s disease. The accuracy of the blood test was validated using data samples from the Wisconsin Alzheimer’s Disease Research Center (ADRC) and the Wisconsin Registry for Alzheimer’s Prevention (WRAP).
In a crucial advancement for Alzheimer’s disease diagnosis, the U.S. Food and Drug Administration (FDA) granted clearance for an Alzheimer’s disease blood test on May 16, 2025. The test is an in vitro diagnostic (IVD) assay capable of detecting amyloid — a key protein involved in Alzheimer’s disease — in blood. Data samples used to evaluate the validity of the test are from research conducted at the University of Wisconsin–Madison.
On behalf of the Wisconsin Alzheimer’s Institute Regional Milwaukee Office, thank you to everyone who attended the 11th Annual Breaking the Silence event!
Caring for a loved one with Alzheimer's or other dementia is a challenging responsibility. The Wisconsin Alzheimer's Institute is dedicated to providing essential support and resources to caregivers, helping them navigate this difficult journey with compassion and expertise.
In the latest episode of the podcast Expert Voices in Dementia, Sterling Johnson, PhD, shares news about detecting Alzheimer's disease through blood testing and the important implications this research could have on Alzheimer's disease treatment. Johnson's lab is investigating p-tau217 as a blood-based biomarker for early detection of Alzheimer's disease.
The selected paper, which utilizes Wisconsin ADRC and WRAP participant data, maps a timeline of amyloid and tau accumulation in the brain
On March 6, Sterling Johnson, PhD, participated in a news conference for the media to discuss the importance of federally funded Alzheimer’s disease research at UW–Madison and its impact on people throughout Wisconsin and nationwide.
To stay informed about federal funding changes that impact UW Alzheimer's disease research programs, read the UW–Madison Office of Federal Relations updates page.
The National Institute of Health (NIH) recognizes February as American Heart Health month. Because there are crucial connections between having a healthy heart and a healthy brain, we’re sharing information from the NIH about preventing heart disease.